Supra-Annular Self-Expanding Versus Intra-Annular Balloon-Expandable Transcatheter Aortic Valve Implantation: A Meta-Analysis of Valve-Related Outcomes
Reviews in Cardiovascular Medicine · 21.04.2026 · 27 (4)
DOI: 10.31083/rcm48459 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Reviews in Cardiovascular Medicine, online erschienen am 21.04.2026. Verfasst von Mohamed Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cardiothoracic Centre, Freeman Hospital, NE7 7DN Newcastle-upon-Tyne, UK. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Transcatheter aortic valve implantation (TAVI) is an established treatment for severe aortic stenosis. The two most widely used platforms are either balloon-expandable intra-annular valve (BEV, Edwards) or self-expanding supra-annular valve (SEV) from Medtronic. Comparative data related to clinical and sub-clinical valve thrombosis are limited. The aim of this study-level meta-analysis is to evaluate its incidence and whether this translates into any difference in clinical outcomes.
Methods
Electronic databases were searched from inception through to October 2025 to identify randomised clinical trials of patients receiving either platform. Rates of clinical and subclinical valve thrombosis were identified and compared between the two groups.
Results
In five randomized controlled trials including 1877 patients, the risk of clinical and sub-clinical valve thrombosis was relatively low in both groups. There was a significant 81% reduction in clinical valve thrombosis in patients undergoing SEV compared to BEV [0.4% vs. 2.1%; rate ratio (RR) 0.19, 95% confidence interval (CI) (0.04 to 0.86), p = 0.03]. Similarly, the risk of sub-clinical valve thrombosis was significantly lower in the SEV group [0.6% vs. 3.6%; RR 0.22, 95% CI (0.07 to 0.65), p = 0.006]. This difference was not translated into increased risk of stroke, valve re-intervention, or death.
Conclusion
Patients undergoing TAVI using SEV compared to BEV have a lower risk of clinical and sub-clinical valve thrombosis in randomized trials, which is largely influenced by small annulus anatomy. Larger studies with longer term follow-up or using a dedicated imaging protocol may provide better insights into the clinical sequelae of this phenomenon.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiothoracic Centre, Freeman Hospital, NE7 7DN Newcastle-upon-Tyne, UK.
- Division of Emergency Medicine, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
- Department of Internal Diseases and Cardiology, Medical University of Warsaw, 02-005 Warsaw, Poland.
- Department of Interventional Cardiology and Internal Diseases, Military Institute of Medicine - National Research Institute, 05-119 Legionowo, Poland.
- Translational and Clinical Research Institute, Newcastle University, NE4 5PL Newcastle-upon-Tyne, UK.
Zitieren
APA
Ali, M., Paraskevi, T., Omari, M., Farag, M., Kuzemczak, M., & Alkhalil, M. (2026). Supra-Annular Self-Expanding Versus Intra-Annular Balloon-Expandable Transcatheter Aortic Valve Implantation: A Meta-Analysis of Valve-Related Outcomes. Reviews in Cardiovascular Medicine, 27(4). https://doi.org/10.31083/rcm48459
Vancouver
Ali M, Paraskevi T, Omari M, Farag M, Kuzemczak M, Alkhalil M. Supra-Annular Self-Expanding Versus Intra-Annular Balloon-Expandable Transcatheter Aortic Valve Implantation: A Meta-Analysis of Valve-Related Outcomes. Reviews in Cardiovascular Medicine. 2026;27(4). doi:10.31083/rcm48459
BibTeX
@article{Ali2026,
author = {Ali, Mohamed and Paraskevi, Trivilou and Omari, Muntaser and Farag, Mohamed and Kuzemczak, Michal and Alkhalil, Mohammad},
title = {Supra-Annular Self-Expanding Versus Intra-Annular Balloon-Expandable Transcatheter Aortic Valve Implantation: A Meta-Analysis of Valve-Related Outcomes},
journal = {Reviews in Cardiovascular Medicine},
year = {2026},
volume = {27},
number = {4},
doi = {10.31083/rcm48459}
}
EUVIMED